CAR-T therapy for lymphoma worked longer when the product had more ‘young’ T cells
An analysis of 580 people with lymphoma treated with the CAR-T therapy axi-cel, published Oct. 23, 2026, in Nature Medicine, found that products with more naive-like T cells were linked to longer…